This company has been marked as potentially delisted and may not be actively trading. Elicio Therapeutics (ELTX) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Elicio Therapeutics (NASDAQ:ELTX)CurrentInstitutional OwnershipPercentage35.03%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$1.06MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$152.75K Get ELTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Elicio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELTX Institutional Buying and Selling by Quarter Elicio Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 Jane Street Group LLC14,993$92K0.0%N/A0.139% 5/15/2025 Royal Bank of Canada36,537$225K0.0%N/A0.339% 5/9/2025 CM Management LLC55,000$339K0.3%+37.5%0.510% 4/28/2025 Moody Lynn & Lieberson LLC10,000$62K0.0%N/A0.093% 2/7/2025 CM Management LLC40,000$204K0.2%-20.0%0.371% 8/15/2024 Armistice Capital LLC100,000$411K0.0%N/A0.978% 8/9/2024 Warberg Asset Management LLC11,801$49K0.0%N/A0.115% 8/2/2024 CM Management LLC50,000$206K0.2%-33.3%0.489% 5/14/2024 CM Management LLC75,000$570K0.5%+50.0%0.733% 8/4/2023 CM Management LLC65,000$618K0.6%N/A2.159% (Data available from 1/1/2016 forward) ELTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Elicio Therapeutics shares: Armistice Capital LLC ($411K), CM Management LLC ($339K), Royal Bank of Canada ($225K), Jane Street Group LLC ($92K), and Moody Lynn & Lieberson LLC ($62K), Warberg Asset Management LLC ($49K).Learn more on ELTX's institutional investors. What percentage of Elicio Therapeutics stock is owned by institutional investors? 35.03% of Elicio Therapeutics stock is owned by institutional investors. Learn more on ELTX's institutional investor holdings. Which institutional investors have been buying Elicio Therapeutics stock? The following institutional investors have purchased Elicio Therapeutics stock in the last 24 months: CM Management LLC ($105K), Armistice Capital LLC ($100K), Royal Bank of Canada ($36.54K), Jane Street Group LLC ($14.99K), Warberg Asset Management LLC ($11.80K), and Moody Lynn & Lieberson LLC ($10K). How much institutional buying is happening at Elicio Therapeutics? Institutional investors have bought a total of 278,331 shares in the last 24 months. This purchase volume represents approximately $1.86M in transactions. Which Elicio Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Elicio Therapeutics stock in the last 24 months: CM Management LLC ($35K). How much institutional selling is happening at Elicio Therapeutics? Institutional investors have sold a total of 35,000 shares in the last 24 months. This volume of shares sold represents approximately $152.75K in transactions. Related Companies CRVS Institutional Ownership TNGX Institutional Ownership AVIR Institutional Ownership LFCR Institutional Ownership ATXS Institutional Ownership RZLT Institutional Ownership AQST Institutional Ownership FHTX Institutional Ownership ALMS Institutional Ownership ANNX Institutional Ownership This page (NASDAQ:ELTX) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elicio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elicio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ELTX Stock Free ELTX Stock Alerts